Orencia (abatacept) - BMS
Myositis induced by immune checkpoint inhibitor therapy (PubMed, Z Rheumatol) - Oct 8, 2026 - "If a myositis-irAE is suspected, high-dose glucocorticoid therapy should be initiated immediately. The treatment often includes glucocorticoid-sparing medications. For severe cases, abatacept should be considered as a salvage therapy. Early detection and close collaboration between all medical specialty disciplines involved are crucial for the prognosis of patients." 
Checkpoint inhibition • Journal • Review • Cardiovascular • Immunology • Myositis • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42844401
 
Helga Lechner-Radner; Karolina Gente; Kastriot Kastrati; Rebecca Hasseli-Fräbel
 
Oct 8, 2026
 
Prev Next